Clinical Trials Directory

Trials / Completed

CompletedNCT03880812

Cost Information on Carpal Tunnel Syndrome Treatment Decisions

Does Societal Cost Information Affect Patient Decision-Making in Carpal Tunnel Syndrome: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
184 (actual)
Sponsor
University of Texas at Austin · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to determine whether the provision of societal cost information affects patients' decisions whether or not to undergo surgical management in carpal tunnel syndrome, using a hypothetical scenario.

Detailed description

Given the large societal costs of carpal tunnel surgery and existence of a relatively inexpensive treatment option, carpal tunnel release provides fertile ground for testing whether societal costs can influence patient decision-making in hand surgery. Such work would inform future efforts to reduce societal healthcare costs by elucidating whether appeals to societal cost are effective at driving stewardship of limited healthcare resources at the patient level. In this study, the investigators aimed to answer this question by presenting participants with a hypothetical scenario in which the participants had to choose between surgery and wrist bracing for carpal tunnel syndrome. Participants were randomized into two cohorts and societal cost information was presented to the intervention group. The effect of societal cost information on treatment choice is assessed, along with participants' healthcare attitudes.

Conditions

Interventions

TypeNameDescription
OTHERSocietal costAnnual societal cost information to the US for carpal tunnel release surgery was displayed.

Timeline

Start date
2018-09-24
Primary completion
2018-12-26
Completion
2018-12-26
First posted
2019-03-19
Last updated
2019-03-19

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03880812. Inclusion in this directory is not an endorsement.